Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment

Judge, R., Parry, M.G., Quail, D., Jacobson, J.G. · 2002 · International Clinical Psychopharmacology

Abstract

Abrupt interruption or cessation of selective serotonin reuptake inhibitor (SSRI) treatment may result in discontinuation or treatment interruption symptoms. Recent reports suggested these symptoms occur more frequently with shorter half-life SSRIs. Previous studies indicated a 5-8-day treatment interruption resulted in fewer discontinuation-emergent adverse events in fluoxetine-treated patients than in paroxetine-treated patients. This study examines the effects of shorter treatment interruption (3-5 days), as would occur if patients miss just a few doses of medication. Patients successfully treated for depression with fluoxetine or paroxetine underwent treatment interruption in a double-blind fashion. Treatment interruption-emergent symptoms were assessed using the Discontinuation-Emergent Signs and Symptoms checklist. Other assessments included the Montgomery-Asberg Depression Rating Scale, Clinical Global Impressions-Severity scale and a social functioning questionnaire. Of 150 patients enrolled, 141 completed the study. Following treatment interruption, fluoxetine-treated patients experienced fewer treatment interruption-emergent events than did paroxetine-treated patients. The paroxetine treatment group also experienced significant increases in depressive symptoms, clinical global severity scores and difficulty in social functioning; the fluoxetine treatment group did not. These results are consistent with reports suggesting abrupt interruption of treatment with paroxet…

Overview

Integrity signals

Registry

Crossref · 10.1097/00004850-200209000-00002

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 3

  1. Benazzi, 1998b, J Psychiatry Neurosci, 23, 94
  2. Dominguez, 1995, Pharmacotherapy, 15, 778
  3. Schatzberg, 1997, J Clin Psychiatry, 58, 5

Cited by

See all 87

Metadata

Authors
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G.
Affiliations
Eli Lilly (United States) (US)
Corresponding author
Jacobson, J.G.
Venue
International Clinical Psychopharmacology
Published
2002-09
Volume
17
Issue
5
Pages
217-225
ISSN
0268-1315 (ISSN-L)
OpenAlex
W1971247978
Cited by
87
References
25
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 10 · 2012: 2
FWCI
3.03
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
discontinuation symptoms, treatment interruption, fluoxetine, paroxetine, selective serotonin reuptake inhibitors, depression, medication adherence, social functioning, adverse drug reactions
MeSH terms
Adult, Depressive Disorder, Double-Blind Method, Female, Fluoxetine, Humans, Male, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Social Behavior, Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. https://app.cochat.ai/papers/10.1097/00004850-200209000-00002
The paper
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G. (2002). Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200209000-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.